About Professor Martin

University Expert

Erika G. Martin, PhD, MPH, is an Assistant Professor of Public Administration and Policy at the Rockefeller College of Public Affairs and Policy and an Institute Fellow at the Nelson A. Rockefeller Institute of Government, University at Albany-State University of New York. Dr. Martin has examined the fairness and flexibility of the federal allocation formula for the Ryan White HIV/AIDS Program, interstate variation in state AIDS Drug Assistance Programs, and the budget impact of expanded HIV screening on government testing, discretionary, and entitlement programs. She is currently researching the effects of the recently repealed ban on federal funding for syringe exchange programs, and has previously analyzed tobacco harm reduction products. In addition to her research in HIV and substance abuse policy, Dr. Martin is actively involved in various projects that examine the public health effects of state vaccination laws, and how media influences public policy and public health practice. Dr. Martin received her BA from Brown University, her MPH in epidemiology from the University of Michigan, and her PhD in health policy and administration from Yale University.

Faculty News:

• Organ donation tax incentives failing: report—New York Daily News, August 31, 2012
• Tax Breaks For Organ Donors Aren't Boosting Transplant Supply—NPR, August 31, 2012
• Faculty Spotlight: Erika Martin discusses major challenges to HIV testing, treatment and care in the U.S.
• Life After the Ban: An Assessment of US Syringe Exchange Programs’ Attitudes About and Early Experiences with Federal Funding
• Rockefeller College's Erika G. Martin Serves on Institute of Medicine Committee Looking at How to Evaluate National HIV Policies
• Rockefeller Experts Consider Healthcare reform

Selected Publications

• Martin EG, Schackman BR. What Does US Health Reform Mean for HIV Clinical Care? JAIDS Journal of Acquired Immune Deficiency Syndromes 2012; 60(1): 72-76.
• Venkataramani AS, Martin EG, Vijayan A, Wellen J. The Impact of State Tax Incentives on Living Organ Donations in the United States. American Journal of Transplantation 2012; 12(8): 2133-40.
• Green TC, Martin EG, Bowman S, Mann M, Beletsky L. One year after lifting the ban on federal funding for syringe exchange and distribution programs: national survey results on the state of programs' applications for and receipt of federal funds. American Journal of Public Health Published 2012; 102(5): e9-e16.
• Martin EG, Barry CL. The adoption of mental health drugs on state AIDS Drug Assistance Program formularies. American Journal of Public Health 101(6): 1103-1109.
• Martin EG, Paltiel AD, Walensky RP, Schackman BR. Expanded HIV screening in the US: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value in Health 2010; 13(8): 893-902.
• Busch SH, Frank RG, Leslie D, Martin A, Rosenheck R, Martin EG, Barry CL. Antidepressants and suicide risk: how did specific information contained in the FDA safety warnings affect treatment pattens in youth? Psychiatric Services 2010;
  61(1): 11-16.
• Martin, EG and PS Keenan. "Sticky dollars: inertia in the evolution of federal allocations for HIV care through the Ryan White Program." Publius: The Journal of Federalism 2009; doi: 10.1093/publius/pjp041
• Pinget C, Martin E, Wasserfallen J-B, Humair J-P, Cornuz J. "Cost-effectiveness analysis of a European primary-care physician training in smoking cessation
  counseling." European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 451-455.
• Martin, EG, Pollack HA, Paltiel AD. "Fact, fiction, and fairness: resource allocation under the Ryan White CARE Act." Health Affairs 2006; 25: 1103-1112.
• Hofner MC, Python NV, Martin EG, Gervasoni JP, Graz B, Yersin B. "Prevalence of victims of violence admitted to an emergency department." Emergency Medicine Journal 2005; 22: 481-485.
• Martin, EG, Warner KE, Lantz PM."Tobacco harm reduction: what do the experts think?" Tobacco Control 2004; 13: 123-128.
• Warner KE, Martin EG. "The U.S. tobacco control community’s view of the future of harm reduction." Tobacco Control 2003; 12: 383-390.